The Dow Chemical Company and Subsidiaries Consolidated Statements of Equity (In millions, except per share amounts) For the years ended Dec 31, 2021 2020 2019 Common Stock Balance at beginning and end of year $ — $ — $ — Additional Paid-in Capital Balance at beginning of year 7,603 7,333 7,042 Issuance of parent company stock - Dow Inc. 320 108 65 Issuance of parent company stock - DowDuPont Inc. — — 28 Stock-based compensation and allocation of ESOP shares 236 162 235 Other — — (37) Balance at end of year 8,159 7,603 7,333 Retained Earnings Balance at beginning of year 16,300 17,313 35,460 Net income (loss) available for The Dow Chemical Company's common stockholder 6,274 1,235 (1,237) Dividends to Dow Inc. (3,264) (2,233) (201) Dividends to DowDuPont Inc. — — (535) Common control transaction — — (16,009) Adoption of accounting standards — — (151) Other (22) (15) (14) Balance at end of year 19,288 16,300 17,313 Accumulated Other Comprehensive Loss Balance at beginning of year (10,855) (10,246) (9,885) Other comprehensive income (loss) 1,878 (609) (1,154) Common control transaction — — 793 Balance at end of year (8,977) (10,855) (10,246) Unearned ESOP Shares Balance at beginning of year (49) (91) (134) Stock-based compensation and allocation of ESOP shares 34 42 45 ESOP shares acquired — — (2) Balance at end of year (15) (49) (91) The Dow Chemical Company's stockholder's equity 18,455 12,999 14,309 Noncontrolling Interests 574 570 553 Total Equity $ 19,029 $ 13,569 $ 14,862 See Notes to the Consolidated Financial Statements. 82